Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment

Th17 cells are implicated in allergic inflammatory diseases, including allergic rhinitis (AR), though the effect of steroids on Th17 cell-dependent nasal responses is unclear. Herein, we investigated a nasal inflammation model elicited by allergen provocation in mice infused with Th17 cells and its...

Full description

Bibliographic Details
Main Authors: Shusaku Ueda, Kento Miura, Hideki Kawasaki, Sawako Ogata, Norimasa Yamasaki, Shuka Miura, Akio Mori, Osamu Kaminuma
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/12/5/674
_version_ 1797501260416417792
author Shusaku Ueda
Kento Miura
Hideki Kawasaki
Sawako Ogata
Norimasa Yamasaki
Shuka Miura
Akio Mori
Osamu Kaminuma
author_facet Shusaku Ueda
Kento Miura
Hideki Kawasaki
Sawako Ogata
Norimasa Yamasaki
Shuka Miura
Akio Mori
Osamu Kaminuma
author_sort Shusaku Ueda
collection DOAJ
description Th17 cells are implicated in allergic inflammatory diseases, including allergic rhinitis (AR), though the effect of steroids on Th17 cell-dependent nasal responses is unclear. Herein, we investigated a nasal inflammation model elicited by allergen provocation in mice infused with Th17 cells and its responsiveness against steroid treatment. We transferred BALB/c mice with Th17 cells, which were differentiated in vitro and showed a specific reaction to ovalbumin (OVA). We challenged the transferred mice by intranasal injection of OVA and to some of them, administered dexamethasone (Dex) subcutaneously in advance. Then, we assessed immediate nasal response (INR), nasal hyperresponsiveness (NHR), and inflammatory cell infiltration into the nasal mucosa. The significant nasal inflammatory responses with massive neutrophil accumulation, INR, and NHR were induced upon allergen challenge. Allergen-induced INR and NHR were significantly suppressed by Dex treatment. This study suggested the effectiveness of steroids on Th17 cell-mediated nasal responses in AR.
first_indexed 2024-03-10T03:15:50Z
format Article
id doaj.art-ae72503b8e2748abbe35dfc044973538
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T03:15:50Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-ae72503b8e2748abbe35dfc0449735382023-11-23T10:13:55ZengMDPI AGBiomolecules2218-273X2022-05-0112567410.3390/biom12050674Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid TreatmentShusaku Ueda0Kento Miura1Hideki Kawasaki2Sawako Ogata3Norimasa Yamasaki4Shuka Miura5Akio Mori6Osamu Kaminuma7Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanDepartment of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanDepartment of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanDepartment of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanDepartment of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanDepartment of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanClinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Kanagawa 252-0392, JapanDepartment of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, JapanTh17 cells are implicated in allergic inflammatory diseases, including allergic rhinitis (AR), though the effect of steroids on Th17 cell-dependent nasal responses is unclear. Herein, we investigated a nasal inflammation model elicited by allergen provocation in mice infused with Th17 cells and its responsiveness against steroid treatment. We transferred BALB/c mice with Th17 cells, which were differentiated in vitro and showed a specific reaction to ovalbumin (OVA). We challenged the transferred mice by intranasal injection of OVA and to some of them, administered dexamethasone (Dex) subcutaneously in advance. Then, we assessed immediate nasal response (INR), nasal hyperresponsiveness (NHR), and inflammatory cell infiltration into the nasal mucosa. The significant nasal inflammatory responses with massive neutrophil accumulation, INR, and NHR were induced upon allergen challenge. Allergen-induced INR and NHR were significantly suppressed by Dex treatment. This study suggested the effectiveness of steroids on Th17 cell-mediated nasal responses in AR.https://www.mdpi.com/2218-273X/12/5/674inflammationnasal hyperresponsivenessTh17 celldexamethasonemouse
spellingShingle Shusaku Ueda
Kento Miura
Hideki Kawasaki
Sawako Ogata
Norimasa Yamasaki
Shuka Miura
Akio Mori
Osamu Kaminuma
Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment
Biomolecules
inflammation
nasal hyperresponsiveness
Th17 cell
dexamethasone
mouse
title Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment
title_full Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment
title_fullStr Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment
title_full_unstemmed Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment
title_short Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment
title_sort th17 dependent nasal hyperresponsiveness is mitigated by steroid treatment
topic inflammation
nasal hyperresponsiveness
Th17 cell
dexamethasone
mouse
url https://www.mdpi.com/2218-273X/12/5/674
work_keys_str_mv AT shusakuueda th17dependentnasalhyperresponsivenessismitigatedbysteroidtreatment
AT kentomiura th17dependentnasalhyperresponsivenessismitigatedbysteroidtreatment
AT hidekikawasaki th17dependentnasalhyperresponsivenessismitigatedbysteroidtreatment
AT sawakoogata th17dependentnasalhyperresponsivenessismitigatedbysteroidtreatment
AT norimasayamasaki th17dependentnasalhyperresponsivenessismitigatedbysteroidtreatment
AT shukamiura th17dependentnasalhyperresponsivenessismitigatedbysteroidtreatment
AT akiomori th17dependentnasalhyperresponsivenessismitigatedbysteroidtreatment
AT osamukaminuma th17dependentnasalhyperresponsivenessismitigatedbysteroidtreatment